NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica™, Inc., (NASDAQ: BIOC), a leading provider of clinical trial management services, today announced that it has appointed James W. Lovett to its Board of Directors, increasing the size of the Board to nine members.
